Skip to main content

Bayer AG

Plant Growth Regulator Market to Hit $5.33B by 2031, MarketsandMarkets Says

Plant Growth Regulator Market to Hit $5.33B by 2031, MarketsandMarkets Says

Delray Beach, Fla. – September 25, 2026 -- The global plant growth regulator market is valued at USD 3.72 billion in 2026 and is projected to reach USD 5.33 billion by 2031, expanding at a compound annual growth rate of 7.4%, according to MarketsandMarkets.

Asia Pacific outpaces global growth as regulators drive bio-based formulations

Asia Pacific is set to post the fastest regional CAGR at 8.8% between 2026 and 2031, fueled by a large agricultural base and rising use of crop-productivity inputs. Europe, led by Germany, France, Italy and Spain, holds a significant market share as regulatory pressure pushes suppliers toward bio-based and environmentally safe formulations for high-value fruit, vegetable and cereal production.

Grünenthal Buys Bayer's Stivarga in Deal Worth Up to €375M

Grünenthal Buys Bayer's Stivarga in Deal Worth Up to €375M

Aachen, Germany – September 21, 2026 -- Grünenthal has agreed to acquire Bayer AG's oncology drug Stivarga® (regorafenib) for up to €375 million, adding an oral cancer treatment sold in more than 90 markets to its portfolio.

Grünenthal expects Stivarga to add up to €100 million to EBITDA in 2027

The German pharmaceutical company said the acquisition is immediately accretive to its business, with an estimated positive impact on consolidated EBITDA of approximately €100 million for the year ending December 31, 2027. That projection assumes the deal closes by the end of 2026 or early 2027 and includes a full year of consolidation.